DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
This Quarter Return
+31.77%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$232M
AUM Growth
+$232M
Cap. Flow
-$33.8M
Cap. Flow %
-14.58%
Top 10 Hldgs %
46.06%
Holding
89
New
6
Increased
21
Reduced
20
Closed
10

Top Buys

1
WVE icon
Wave Life Sciences
WVE
$5.54M
2
SAGE
Sage Therapeutics
SAGE
$3.1M
3
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
$2.39M
4
BPMC
Blueprint Medicines
BPMC
$2.16M
5
MRSN icon
Mersana Therapeutics
MRSN
$2.12M

Top Sells

1
LOXO
Loxo Oncology, Inc
LOXO
$25.4M
2
NXTM
NxStage Medical Inc.
NXTM
$8.93M
3
ADXS
Advaxis, Inc.
ADXS
$8.65M
4
ASND icon
Ascendis Pharma
ASND
$3.87M
5
ARGX icon
argenx
ARGX
$2.83M

Sector Composition

1 Healthcare 88.92%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LRMR icon
51
Larimar Therapeutics
LRMR
$310M
$910K 0.39% 332,000 +259,721 +359% +$712K
MGNX icon
52
MacroGenics
MGNX
$112M
$899K 0.39% 50,000 -28,305 -36% -$509K
SPRO icon
53
Spero Therapeutics
SPRO
$116M
$897K 0.39% 70,000 – –
ABUS icon
54
Arbutus Biopharma
ABUS
$711M
$884K 0.38% 246,900 – –
RDUS
55
DELISTED
Radius Health, Inc.
RDUS
$837K 0.36% 42,000 +21,500 +105% +$428K
MDGL icon
56
Madrigal Pharmaceuticals
MDGL
$9.76B
$827K 0.36% 6,600 – –
SVRA icon
57
Savara
SVRA
$567M
$813K 0.35% +110,275 New +$813K
PHAS
58
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$689K 0.3% 72,500 -27,500 -28% -$261K
KALV icon
59
KalVista Pharmaceuticals
KALV
$678M
$665K 0.29% 23,225 +3,000 +15% +$85.9K
KURA icon
60
Kura Oncology
KURA
$686M
$606K 0.26% 36,558 -112,059 -75% -$1.86M
CDTX icon
61
Cidara Therapeutics
CDTX
$1.66B
$564K 0.24% 212,766 – –
OBSV
62
DELISTED
ObsEva SA Ordinary Shares
OBSV
$555K 0.24% 43,408 -930 -2% -$11.9K
URGN icon
63
UroGen Pharma
URGN
$900M
$554K 0.24% 15,000 – –
ALDX icon
64
Aldeyra Therapeutics
ALDX
$351M
$452K 0.2% 50,000 – –
MASI icon
65
Masimo
MASI
$7.59B
$415K 0.18% 3,000 – –
STRO icon
66
Sutro Biopharma
STRO
$72.7M
$359K 0.15% 31,494 – –
RIGL icon
67
Rigel Pharmaceuticals
RIGL
$697M
$354K 0.15% 137,600 – –
ARCT icon
68
Arcturus Therapeutics
ARCT
$462M
$323K 0.14% 47,255 -25,550 -35% -$175K
NERV icon
69
Minerva Neurosciences
NERV
$16.5M
$284K 0.12% 36,084 +10,000 +38% +$78.7K
SLGL icon
70
Sol-Gel Technologies
SLGL
$63.5M
$237K 0.1% 35,000 – –
RNTX
71
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
$194K 0.08% +99,502 New +$194K
LCTX icon
72
Lineage Cell Therapeutics
LCTX
$267M
$124K 0.05% 95,000 -5,000 -5% -$6.53K
BLCM
73
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$101K 0.04% 30,000 – –
IMMU
74
DELISTED
Immunomedics Inc
IMMU
$97K 0.04% 5,052 -77,202 -94% -$1.48M
ORMP icon
75
Oramed Pharmaceuticals
ORMP
$90.2M
$95K 0.04% 26,000 +10,000 +63% +$36.5K
1 2
3
4